List of Cases |
International
Business (English Language) 3k. |
|
|
|
Presentations
submission timeliness, slide quality, oratorical art, audience involvement in
the case study 0-3 |
The complexity of
the analyzed problem 0-3 |
Case studies
breadth, i.e. quite a lot of work done 0-4 |
Depth of the case
analysis, i.e. use sophisticated analytical techniques 0-4 |
It was collected an
additional, interesting and valuable material on the Internet 0-2 |
A summary of the
findings, what is memorable, the most valuable of the case presented, where
you can apply the acquired knowledge 0-2 |
Working as opponent of the peer
presentations or active participation in the cases analysis 0-1. Good questions or comments prized pluses,
3-4 pluses equal to 1 point. |
|
|
|
|
|
|
|
|
|
|
# |
Page |
Case |
The names
of students who analyzed the case |
Date of
presentation |
Presentations
queue |
Slides of
the presentation |
Additional
material 1 |
Additional
material 2 |
Assessment
of case study |
1 |
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
2 |
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
3 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Augustinas Janutaitis |
2021-05-06 |
5 |
|
|
|
9 |
2 |
3 |
2 |
|
1 |
1 |
|
4 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Dovydas Stasytis |
2021-05-06 |
5 |
|
|
|
10 |
2 |
3 |
2 |
|
1 |
1 |
1 |
|
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Aušrinė Šapkaitė |
2021-05-06 |
5 |
|
|
|
9 |
2 |
3 |
2 |
|
1 |
1 |
|
5 |
377-379 |
Tree Values |
|
|
|
|
|
|
9 |
2 |
3 |
2 |
|
1 |
1 |
|
6 |
377-379 |
Tree Values |
|
|
|
|
|
|
9 |
2 |
3 |
2 |
|
1 |
1 |
|
|
377-379 |
Tree Values |
|
|
|
|
|
|
9 |
2 |
3 |
2 |
|
1 |
1 |
|
7 |
381-394 |
The Super Project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
8 |
381-394 |
The Super project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
381-394 |
The Super project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
9 |
395-403 |
Net Flix |
Tigran Avagyan |
2021-05-06 |
1 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
1 |
10 |
395-403 |
Net Flix |
Ričardas
Granickas |
2021-05-06 |
1 |
|
|
|
9 |
3 |
2 |
2 |
|
1 |
1 |
|
|
395-403 |
Net Flix |
Artūras
Maciunskas |
2021-05-06 |
1 |
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
1 |
|
395-403 |
Net Flix |
Murauskaitė
Gintarė |
2021-05-06 |
2 |
|
|
|
8 |
2 |
2 |
2 |
|
1 |
1 |
|
|
395-404 |
Net Flix |
Pulokaitė
Gabija |
2021-05-06 |
2 |
|
|
|
8 |
2 |
2 |
2 |
|
1 |
1 |
|
|
395-403 |
Net Flix |
Dilinikaitytė
Ieva Patricija |
2021-05-06 |
2 |
|
|
|
8 |
2 |
2 |
2 |
|
1 |
1 |
|
11 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
12 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
13 |
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
14 |
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
15 |
405-418 |
Whirlpool Europe |
Duvillard Marie |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
16 |
405-418 |
Whirlpool Europe |
Bétend Romane |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
405-418 |
Whirlpool Europe |
Évaux Baptistee |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
405-418 |
Whirlpool Europe |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
17 |
431-434 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
18 |
431-435 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
19 |
431-436 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
20 |
431-437 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
21 |
431-438 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
22 |
431-439 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
23 |
431-440 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
24 |
431-441 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
25 |
431-442 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
18 |
431-443 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
19 |
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
Evilė Raupelytė |
2021-05-06 |
7 |
|
|
|
10 |
2 |
2 |
3 |
|
1 |
1 |
1 |
20 |
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
Aistė Prialgauskaitė |
2021-05-06 |
7 |
|
|
|
10 |
2 |
2 |
3 |
|
1 |
1 |
1 |
21 |
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
22 |
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
23 |
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
24 |
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
25 |
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Ieva Skirkevičiūtė |
2021-05-06 |
4 |
|
|
|
10 |
2 |
2 |
3 |
|
1 |
1 |
1 |
26 |
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Milda Milaknytė |
2021-05-06 |
4 |
|
|
|
10 |
2 |
2 |
3 |
|
1 |
1 |
1 |
27 |
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Domantė Janulytė |
2021-05-06 |
4 |
|
|
|
10 |
2 |
2 |
3 |
|
1 |
1 |
1 |
28 |
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Arif Emre Demir |
2021-05-06 |
6 |
|
|
|
8 |
2 |
2 |
2 |
|
1 |
1 |
|
29 |
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Zhengli
Jin |
2021-05-06 |
6 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
1 |
1 |
30 |
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Refikcan Korkmaz |
2021-05-06 |
6 |
|
|
|
8 |
2 |
2 |
2 |
|
1 |
1 |
|
31 |
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
32 |
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
33 |
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
34 |
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
35 |
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
36 |
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
37 |
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Agnė Sukackaitė, |
2021-05-06 |
3 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
38 |
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Aistė
Sedlevičiūtė |
2021-05-06 |
3 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
39 |
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Aušrinė Krūminytė. |
2021-05-06 |
3 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
40 |
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
41 |
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
42 |
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43 |
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
44 |
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
45 |
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
46 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
47 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
48 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|